This application requests the third renewal of our Chemistry-Biology Interface (CBI) Training Grant. In 1995 we launched a new interdisciplinary training program at the University of Massachusetts that built on existing strengths and harnessed our faculty commitment to collaboration between the physical and life sciences. We successfully implemented a curriculum that complemented the requirements of the participating graduate programs, adding enough training elements to efficiently train students with either chemical or biological backgrounds in the complementary discipline. The subsequent period (2000-2005) was one of tremendous growth of the program: the number of affiliated students grew from 14 to over 60, as students well beyond those with CBI funding recognized the value of the CBI training and community. During the current funding period our CBI Training Program has become a major force on campus, influencing faculty hiring and construction of new buildings and renovations. The CBI Training Faculty has grown from 19 to 27, and continues to provide cross-training to over 60 students from the four participating graduate programs of Chemistry, Molecular &Cellular Biology, Chemical Engineering, and Polymer Science &Engineering. We anticipate continued growth of our CBI Program as additional departments (notably Physics and Computer Science) move into CBI- related areas. The CBI Program currently provides NIH support for 6 pre-doctoral students, and a University match supports 2 additional Traineeships. To continue to foster the growing strength of the CBI program as it expands into new disciplines and trains increasing numbers of students, we request an increase to 8 NIH-funded Traineeships. Notable features of our CBI Program include the participation of the Departments of Chemical Engineering and Polymer Science &Engineering, which enriches CBI training with quantitative, biomaterials, and bioengineering perspectives and projects. Our popular """"""""Drug Design"""""""" course, developed as an integral part of the CBI curriculum, features weekly seminars by speakers from the pharmaceutical industry and a field trip to tour a company. Our CBI retreat has grown into a vibrant annual event that forges connections with researchers at UMass Medical School. Finally, CBI students, in partnership with students of the new UMass Institute for Cellular Engineering, are organizing a new annual Career Day to further enhance their CBI training. Thus the CBI curriculum and community are rich in opportunities for training in the methods and intellectual framework of both chemistry and biology, which prepares our CBI graduates to pose and solve significant biomedical questions in their future work.

Public Health Relevance

Understanding the causes of a disease and developing new treatments requires scientists to apply the concepts and methods of both chemistry and biology. Graduate students pursuing the Ph.D. in either chemical or biological sciences at UMass have the opportunity to be trained in the complementary discipline through the curriculum and interactions of the Chemistry-Biology Interface (CBI) Training Program. This training prepares them for productive careers in the biomedical sciences in industrial, academic, or governmental laboratories.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008515-19
Application #
8683183
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Fabian, Miles
Project Start
1995-07-15
Project End
2016-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
19
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Massachusetts Amherst
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Amherst
State
MA
Country
United States
Zip Code
01003
Luther, D C; Lee, Y W; Nagaraj, H et al. (2018) Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges. Expert Opin Drug Deliv 15:905-913
Tubeleviciute-Aydin, Agne; Zhou, Libin; Sharma, Gyanesh et al. (2018) Rare human Caspase-6-R65W and Caspase-6-G66R variants identify a novel regulatory region of Caspase-6 activity. Sci Rep 8:4428
Joshi, Bishnu P; Hardie, Joseph; Mingroni, Michael A et al. (2018) Surface-Modified Macrophages Facilitate Tracking of Breast Cancer-Immune Interactions. ACS Chem Biol 13:2339-2346
Shave, Molly K; Kalasin, Surachate; Ying, Eric et al. (2018) Nanoscale Functionalized Particles with Rotation-Controlled Capture in Shear Flow. ACS Appl Mater Interfaces 10:29058-29068
Gao, Jingjing; Zhao, Bo; Wang, Meizhe et al. (2018) Supramolecular Assemblies for Transporting Proteins Across an Immiscible Solvent Interface. J Am Chem Soc 140:2421-2425
Scaletti, Federica; Hardie, Joseph; Lee, Yi-Wei et al. (2018) Protein delivery into cells using inorganic nanoparticle-protein supramolecular assemblies. Chem Soc Rev 47:3421-3432
Mahmoud, Samar A; Chien, Peter (2018) Regulated Proteolysis in Bacteria. Annu Rev Biochem 87:677-696
Hayashi, Jennifer M; Richardson, Kirill; Melzer, Emily S et al. (2018) Stress-Induced Reorganization of the Mycobacterial Membrane Domain. MBio 9:
Lamriben, Lydia; Hebert, Daniel N (2018) Activating and Repressing IRE1?: The Hsp47 and BiP Tug of War. Mol Cell 69:159-160
Joshi, Bishnu P; Hardie, Joseph; Farkas, Michelle E (2018) Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods. Chemistry 24:8717-8726

Showing the most recent 10 out of 241 publications